Buprenorphine and Pipamperone: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Buprenorphine
Pipamperone
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both buprenorphine (a pain and addiction medicine) and pipamperone (an antipsychotic-type medicine) can affect the heart's electrical timing, something called the QT interval. When two medicines that do this are taken together, the effect can add up, which in rare cases can lead to an irregular heartbeat.
This is a theoretical concern, meaning it hasn't been proven when these two are combined, but it's worth taking seriously, especially if you have heart issues or low potassium or magnesium levels. The good news is your care team can manage this. Please don't stop either medicine on your own. Just talk with your doctor or pharmacist so they can watch you closely.
Interaction: Additive QT-interval prolongation when buprenorphine is combined with pipamperone. Both agents independently carry QT-prolonging potential; neither is a prodrug, so the effect is pharmacodynamic (additive), not a metabolic activation/inactivation issue.
- Direction: Increased combined risk of QT prolongation and, rarely, torsades de pointes.
- Evidence: Theoretical; magnitude of combined risk not established.
- Onset: Unspecified.
- Management: Avoid concomitant use where possible. If used, assess baseline risk factors (hypokalemia, hypomagnesemia, bradycardia, CHF, baseline/congenital QT prolongation, recent AF conversion, digitalis therapy). Correct electrolytes; consider baseline and follow-up ECG monitoring.
What happens
An increased risk of QT interval prolongation
Interaction Deep Dive
Do not use buprenorphine together with medications capable of extending the QT interval342. It remains unknown what risk arises from pairing buprenorphine with additional agents that cause QT prolongation. When prescribing buprenorphine to patients presenting with risk factors, including hypokalemia, bradycardia, recent conversion from atrial fibrillation, congestive heart failure, digitalis therapy, baseline QT prolongation, subclinical long-QT syndrome, or severe hypomagnesemia, take these observations into account in clinical decision-making1.
Why it happens (mechanism)
Additive QT interval prolongation
How to manage this interaction
Your care team can manage this combination safely with a few sensible steps:
- Keep taking both medicines as prescribed unless your doctor tells you otherwise.
- Your team may check an ECG and review your heart history before and during treatment.
- They may check and correct your potassium and magnesium levels, since low levels raise the risk.
- In some cases they may choose an alternative medicine to avoid combining the two.
Tell your pharmacist or prescriber if you have a history of heart rhythm problems, fainting, or take other heart medicines. Report any dizziness, palpitations, or fainting right away.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Buprenorphine and Pipamperone together?
Combining buprenorphine and pipamperone can add up their effects on your heart's rhythm, so your care team may avoid the pair or monitor you closely with ECGs and electrolyte checks. Keep taking both as prescribed and report any dizziness or palpitations. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Buprenorphine and Pipamperone interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Buprenorphine and Pipamperone interaction managed?
Your care team can manage this combination safely with a few sensible steps: Keep taking both medicines as prescribed unless your doctor tells you otherwise. Your team may check an ECG and review your heart history before and during treatment. They may check and correct your potassium and magnesium levels, since low levels raise the risk. In some cases they may choose an alternative medicine to av… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Buprenorphine or Pipamperone need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (4)
- Product Information: BRIXADI(TM) subcutaneous extended-release injection, buprenorphine subcutaneous extended-release injection. Braeburn Inc (per FDA), Plymouth Meeting, PA, 2023. DailyMed
- Product Information: BUTRANS(R) transdermal system patch, buprenorphine transdermal system patch. Purdue Pharma L.P. (per FDA), Stamford, CT, 2016. DailyMed
- Product Information: BELBUCA(TM) buccal film, buprenorphine buccal film. Endo Pharmaceuticals Inc. (per FDA), Malvern, PA, 2016.
- Product Information: BUPRENEX(R) intravenous injection, intramuscular injection, buprenorphine HCl intravenous injection, intramuscular injection. Indivior Inc. (per DailyMed), Richmond, VA, 2016. DailyMed
Keep reading about Buprenorphine
Keep reading about Pipamperone
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist